RONNIE ISAACSON: Open Payments
NPI 1275007965 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 61 payments from 15 companies in 2025. Trend: 2023 $703 · 2024 $942 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $193 |
| Neurocrine BioSciences, Inc. | 7 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $146 |
| Janssen Pharmaceuticals, Inc | 7 | $145 |
| Lundbeck LLC | 6 | $109 |
| Teva Pharmaceuticals USA, Inc. | 4 | $87 |
| Biogen, Inc. | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
Products named: VRAYLAR, INGREZZA, TRINTELLIX, REXULTI, SPRAVATO, AUSTEDO XR, INVEGA SUSTENNA, ZURZUVAE.
Industry payments across ID — which companies pay providers there.
